Search results
Results From The WOW.Com Content Network
Mycoses: Diagnosis, Therapy and Prophylaxis of Fungal Diseases is a monthly peer-reviewed medical journal covering mycology. It is published by Wiley-Blackwell. The editor-in-chief are Oliver Cornely, Jacques Meis and Martin Schaller. It is the official publication of the Deutschsprachige Mykologische Gesellschaft.
International Journal of Medicinal Mushrooms: Journal of Fungi: MDPI (Basel, Switzerland) 2015– Journal of Mycology: Manhattan 1885–1908, replaced by Mycologia: Medical Mycology: Taylor and Francis, Volume 1–23 published as Sabouraudia and Volumes 24–33 published as Journal of Medical and Veterinary Mycology: 1972– MycoKeys: Pensoft ...
Download as PDF; Printable version; ... Pages in category "Mycology journals" The following 22 pages are in this category, out of 22 total. ... Mycoses (journal ...
Fungal infection, also known as mycosis, is a disease caused by fungi. [ 5 ] [ 13 ] Different types are traditionally divided according to the part of the body affected; superficial, subcutaneous , and systemic.
Scedosporiosis is the general name for any mycosis – i.e., fungal infection – caused by a fungus from the genus Scedosporium.Current population-based studies suggest Scedosporium prolificans (also known and recently more commonly referred to as Lomentospora prolificans) and Scedosporium apiospermum to be among the most common infecting agents from the genus, [1] although infections caused ...
Phaeohyphomycosis is a diverse group of fungal infections, [6] caused by dematiaceous fungi whose morphologic characteristics in tissue include hyphae, yeast-like cells, or a combination of these. [7]
A dermatomycosis is a skin disease caused by a fungus.Most dermatomycoses are mild and resolve without treatment, but many are treated clinically with topical antifungal medicines.
It has the highest prevalence of all systemic mycoses (fungal infections) in the area. [12] As many as 75% of people in endemic areas have been estimated to be infected with the asymptomatic form (up to 10 million people), with 2% developing clinically significant disease. [ 12 ]